Hewlett Packard Enterprise and Novartis join forces to advance Novartis global health efforts

JUNE 23, 2021 • NEWS ADVISORY

TAP IMAGE TO ZOOM IN

IN THIS ARTICLE

  • Data-related insights are essential to improve access to healthcare and medicines 
  • HPE is is collaborating with Novartis to collect and integrate complex data sources across organizations globally, providing data transparency at scale to inform targeted response strategies

The first use case for the partnership will seek to develop a disease surveillance solution for dengue fever, initially focusing on India

HOUSTON, Texas – June 23, 2021 – Novartis and Hewlett Packard Enterprise (NYSE: HPE) today announced a collaboration that aims to accelerate the use of data and digital technologies within Novartis efforts to reimagine global health, and improve access to healthcare and medicines.

The collaboration will focus on three global health enablers: identifying and integrating complex data sources related to health; advancing the application of artificial intelligence, machine learning and geo-spatial analytics to these data; and expanding access to technology in remote and underserved locations.

Data-related insights are essential to improve access to healthcare and medicines, especially in low-resource settings, because they enable decision makers to target interventions to achieve the greatest impact. However, data is often unavailable, outdated, incomplete or not in digital form. Novartis and HPE therefore aim to identify and integrate diverse data sources to enable real-time disease insights to inform targeted response strategies. 

“HPE and Novartis are working together to collect and integrate complex data sources across organizations globally to provide data transparency at scale ,” says Janice Zdankus, Vice President, Innovation for Social Impact, Office of the CTO, Hewlett Packard Enterprise. “In the past, the ability to realize such global data insights has been limited by location, governance, quality and trustworthiness of the data, and by the capacity to run analytics in an efficient and economical way. We want to democratize the access to data, analytics and AI by making them more accessible to domain experts, citizen users, and data scientists. To that end, we will deploy a disruptive approach for creating dataspaces, using open source as the foundation, combined with solutions such as the HPE Ezmeral Software Platform.”

Disease surveillance solution to help remediate the growing threat of dengue fever

The first use case for the partnership will seek to develop a disease surveillance solution for dengue fever, initially focusing on India. More than 3.9 billion people in over 129 countries are at risk of contracting dengue fever, with an estimated 400 million cases and 40,000 deaths each year. The World Health Organization has identified dengue fever as one of the top ten global health threats.

Together, Novartis and HPE aspire to help remediate the growing threat of dengue fever by developing publicly available insights to help authorities proactively deploy response strategies targeting at-risk populations. The resulting real-world evidence will complement the drug-discovery efforts of the Novartis Institute for Tropical Diseases, which is dedicated to finding new medicines to treat neglected, infectious diseases including Dengue fever.

Event note
 

About Hewlett Packard Enterprise

Hewlett Packard Enterprise (NYSE: HPE) is the global edge-to-cloud company that helps organizations accelerate outcomes by unlocking value from all of their data, everywhere. Built on decades of reimagining the future and innovating to advance the way people live and work, HPE delivers unique, open and intelligent technology solutions delivered as a service – spanning Compute, Storage, Software, Intelligent Edge, High Performance Computing and Mission Critical Solutions – with a consistent experience across all clouds and edges, designed to help customers develop new business models, engage in new ways, and increase operational performance. For more information, visit: www.hpe.com 

RELATED NEWS